Argenx to present at upcoming investor conferences

May 3 1 , 202 3 amsterdam , the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in two upcoming investor conferences in june:

ARGX Ratings Summary

ARGX Quant Ranking